Atlas Trials

Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease

Clinical trial NCT05728684 · UNKNOWN

Trial details

NCT number
NCT05728684
Sponsor
Beijing Friendship Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
IgG4 Related Disease
Start date
2023-02-28
Primary completion
2024-02-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.